AC Immune SA (ACIU)
2.57
+0.05
(+1.98%)
USD |
NASDAQ |
Oct 07, 16:00
2.555
-0.02
(-0.58%)
After-Hours: 20:00
AC Immune Market Cap : 234.13M for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 234.13M |
| October 06, 2026 | 229.57M |
| October 05, 2026 | 246.88M |
| October 02, 2026 | 248.25M |
| October 01, 2026 | 255.99M |
| September 30, 2026 | 238.68M |
| September 29, 2026 | 236.86M |
| September 28, 2026 | 237.77M |
| September 25, 2026 | 229.57M |
| September 24, 2026 | 242.32M |
| September 23, 2026 | 257.81M |
| September 22, 2026 | 248.70M |
| September 21, 2026 | 241.87M |
| September 18, 2026 | 239.59M |
| September 17, 2026 | 244.15M |
| September 16, 2026 | 241.41M |
| September 15, 2026 | 244.15M |
| September 14, 2026 | 242.32M |
| September 11, 2026 | 251.43M |
| September 10, 2026 | 245.06M |
| September 09, 2026 | 251.43M |
| September 08, 2026 | 253.26M |
| September 04, 2026 | 260.54M |
| September 03, 2026 | 266.92M |
| September 02, 2026 | 258.72M |
| Date | Value |
|---|---|
| September 01, 2026 | 244.15M |
| August 31, 2026 | 240.50M |
| August 28, 2026 | 241.41M |
| August 27, 2026 | 246.88M |
| August 26, 2026 | 259.63M |
| August 25, 2026 | 266.01M |
| August 24, 2026 | 260.54M |
| August 21, 2026 | 264.19M |
| August 20, 2026 | 240.50M |
| August 19, 2026 | 235.04M |
| August 18, 2026 | 234.13M |
| August 17, 2026 | 230.48M |
| August 14, 2026 | 226.84M |
| August 13, 2026 | 234.13M |
| August 12, 2026 | 238.68M |
| August 11, 2026 | 231.39M |
| August 10, 2026 | 207.71M |
| August 07, 2026 | 215.00M |
| August 06, 2026 | 211.35M |
| August 05, 2026 | 208.62M |
| August 04, 2026 | 206.28M |
| August 03, 2026 | 225.87M |
| July 31, 2026 | 222.82M |
| July 30, 2026 | 241.13M |
| July 29, 2026 | 230.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Precigen, Inc. | 2.699B |
| Basilea Pharmaceutica AG | 945.73M |
| Santhera Pharmaceuticals Holding AG | 274.57M |
| BeOne Medicines Ltd. | 37.92B |
| CRISPR Therapeutics AG | 5.060B |
Market Cap Related Metrics
| PS Ratio | 11.14 |
| Price to Book Value | 5.370 |
| Price | 2.57 |
| Earnings Yield | -21.63% |